Skip to content

Endocrine system, metabolism and diabetes

How common are endocrine and metabolic problems among Indian Employees?

Section titled “How common are endocrine and metabolic problems among Indian Employees?”
Of all hospitalizations are endocrine
1.24%
Of endocrine claims are diabetes
45.9%
Of employees have at least one abnormal metabolic or thyroid marker
50.1%
Men aged 31 to 35 have abnormal HbA1c
1 in 4

The system you’re not tracking, but which drives your claims.

When an employee is constantly fatigued, gaining weight despite no lifestyle change, or struggling with focus and mood, the root cause often isn’t burnout. It’s their endocrine system.

The endocrine system is the body’s regulation layer. It uses hormones to control energy levels, blood sugar, stress response, metabolism and reproductive function. These processes determine whether an employee can sustain energy, recover from illness and remain productive over time.

Unlike injuries or infections, endocrine dysfunction develops slowly. Employees continue working while the underlying metabolic control system weakens. The early stages rarely trigger hospitalization, but they steadily increase the likelihood of diabetes, cardiac disease, kidney failure and pregnancy complications later.

In working-age adults, the endocrine system’s primary role is maintenance: keeping blood sugar stable, regulating metabolism and ensuring hormonal balance. When this regulation begins to fail, through insulin resistance, thyroid dysfunction, or metabolic imbalance, the effects first appear as fatigue, slower recovery and declining resilience. Hospitalisation occurs much later, after years of unmanaged progression.

This chapter examines endocrine and metabolic hospitalizations alongside employee screening data. Together, they reveal a key structural risk: low inpatient incidence today, but a large and growing pipeline of future chronic disease.

Endocrine hospitalizations currently account for 1.24% of all admissions. This appears small. But endocrine dysfunction is not an isolated category. It is the upstream driver behind many of the most expensive claims in cardiac, kidney and maternity care.

Section titled “What share of health insurance claims in India are endocrine or diabetes-related?”

This chapter follows claims across the full spectrum of metabolic and endocrine hospitalizations.

Condition Share Age concentration Gender skew Risk interpretation
Diabetes mellitus 45.9% Predominantly above age 50 Male skew Late-stage metabolic disease and primary cost driver
Metabolic disorders 27.3% Present across all ages, including working population Near parity Early metabolic dysfunction and precursor to diabetes
Thyroid disorders 8.8% Peak at ages 31–40 Female skew Working-age hormonal disorder with productivity implications
Other glucose regulation disorders 8% Majority above age 50 Male skew Advanced glucose instability
Other endocrine disorders (PCOS, hormonal) 6.6% Concentrated in ages 21–30 Strong female skew Early endocrine dysfunction in working population
Obesity and hyperalimentation 1.7% Mid-career and older Female skew Low frequency, high severity metabolic condition
Nutritional deficiencies 1.6% Young adults and elderly Balanced Dietary and metabolic imbalance

Most endocrine disorders are not hospitalized when they begin. They are managed through outpatient consultations, daily medication and periodic blood tests.

Hospitalization occurs only after complications develop, such as uncontrolled diabetes, cardiac events, kidney failure or pregnancy complications.

This creates a visibility gap. The underlying metabolic disease progresses quietly for years before appearing as a hospital claim. As a result, endocrine dysfunction often appears indirectly, embedded within other categories such as heart disease, kidney disease, complicated pregnancies and infections with delayed recovery. This explains why metabolic risk drives major claim costs without appearing as a large standalone category.

What does the data say about diabetes and metabolic risk in India’s workforce?

Section titled “What does the data say about diabetes and metabolic risk in India’s workforce? ”

Endocrine dysfunction is not isolated. It increases severity across multiple systems:

  • Cardiac disease risk rises with poor glucose and lipid control
  • Kidney disease progression is strongly driven by diabetes
  • Pregnancy complications increase with thyroid and glucose imbalance
  • Infection recovery slows in metabolically compromised individuals

Is diabetes hospitalization the start or the end of the disease?

Section titled “Is diabetes hospitalization the start or the end of the disease?”

Diabetes accounts for 45.9% of endocrine hospitalizations, making it the largest contributor in this chapter. The highest concentration occurs in older age groups, especially parents. This reflects cumulative metabolic deterioration over time.

This is the critical point for HR leaders: diabetes hospitalization is not the beginning of the disease. It is the result of years of unmanaged metabolic dysfunction. By the time hospitalization occurs, prevention opportunities have already been missed.

Employee-level diabetes hospitalizations indicate progression already underway within the workforce, not just dependent risk.

What is metabolic syndrome, and how common is it among Indian employees?

Section titled “What is metabolic syndrome, and how common is it among Indian employees?”

Metabolic disorders (gout, high cholesterol and metabolic syndrome) account for 27.3% of this chapter. If diabetes is the fire, metabolic syndrome is the smoke. It shows up years before the diabetes diagnosis. National data puts metabolic syndrome prevalence at 30 to 40% of urban Indian adults.

Employees and spouses together contribute over one-third of endocrine claims. Thyroid and other endocrine gland disorders contribute 15.4% combined, concentrated in working-age populations. Female representation is elevated in hormonal disorder categories.

Metabolic and hormonal disorders represent earlier stages in the metabolic disease lifecycle. Their concentration in working-age individuals confirms that endocrine dysfunction is already present within the active workforce. These conditions typically precede diabetes and chronic disease progression, making them important indicators of future risk.

At what age does abnormal blood sugar start in Indian employees?

Section titled “At what age does abnormal blood sugar start in Indian employees?”

There are two key blood sugar tests. Fasting blood sugar (FBS) measures blood sugar at a single point in time. HbA1c reflects a 3-month average, making it a more reliable indicator of whether someone is at risk of diabetes and the most reliable indicator of diabetes risk progression. Screening data shows clear age-linked escalation:

Abnormal HbA1c, by age

  • Male
  • Female
View as table
CategoryMaleFemale
25 and under7%14%
26–3015%12%
31–3527%17%
36–4031%27%
41+54%54%
Source: Pazcare screening data. Read from the original chart and approximate; the 54% at 41+ for both genders is quoted in the text.

Abnormal fasting blood sugar, by age

  • Male
  • Female
View as table
CategoryMaleFemale
25 and under3%3%
26–306%4%
31–3512%7%
36–4018%17%
41+38%37%
Source: Pazcare screening data. Read from the original chart and approximate.

The convergence at 54% for both genders after 41 is the most important number here. Before age 41, men carry a higher blood sugar risk. After 41, women catch up entirely, driven by the metabolic shift that accompanies menopause, which causes insulin sensitivity to decline sharply. An HR team that runs diabetes management programmes targeting only men over a certain age is missing half of the at-risk population.

By age 31 to 35, 1 in 4 male employees already shows abnormal HbA1c. These employees are not diabetic yet. But they are on the path. The screening flags appearing today are the diabetes hospitalization claims of 2028 to 2030.

This explains the future pipeline of chronic disease claims already forming inside the workforce.

How common are thyroid problems among women employees in India?

Section titled “How common are thyroid problems among women employees in India?”

TSH (Thyroid Stimulating Hormone) is the primary screening test for thyroid problems. When TSH is abnormal, it usually means the thyroid gland is either working too hard or not hard enough.

Thyroid disorders account for 8.8% of endocrine hospitalizations and represent the second-highest cost category in this chapter. 60.3% of thyroid claims occur in women.

For women, thyroid abnormalities climb steadily. By age 31 to 35, 1 in 5 women have abnormal TSH. For men, the rate stays mostly flat at 12 to 16% across all age groups.

Abnormal TSH, by age

  • Female
  • Male
View as table
CategoryFemaleMale
25 and under16%15%
26–3019%14%
31–3521%12%
36–4022%15%
41+25%16%
Source: Pazcare screening data. Read from the original chart and approximate; the 12 to 16% range for men and about 1 in 5 for women aged 31 to 35 are quoted in the text.

This matters for two reasons. First, most of these women don’t know they have a thyroid problem. They’re experiencing fatigue, weight gain and mood changes and assuming it’s work stress. Second, untreated thyroid problems during pregnancy double the risk of miscarriage and pre-eclampsia. Most of these women are walking around with a treatable condition that is quietly increasing their health risk.

What percentage of employees have abnormal metabolic or thyroid markers?

Section titled “What percentage of employees have abnormal metabolic or thyroid markers?”

Screening data shows that 50.1% of employees have at least one abnormal metabolic or thyroid marker. These abnormalities appear years before hospitalization.

Share of abnormal markers, by test

View as table
CategoryShare of abnormal markers
HbA1c31.3%
Urine creatinine22.6%
TSH18.8%
Epithelial cells16.4%
Pus cells10.9%
Source: Pazcare screening data. The values are read from labels that are garbled in the PDF; they add up to 100%.

This creates a clear structural gap: high metabolic risk prevalence today, but low hospitalization visibility. Without intervention, a portion of this population will progress to diabetes, kidney disease and cardiac events.

These findings highlight a substantial gap between metabolic risk prevalence and hospitalization incidence. Screening abnormalities typically emerge several years before clinical disease progression and inpatient utilisation.

How do endocrine and metabolic disorders affect workplaces?

Section titled “How do endocrine and metabolic disorders affect workplaces?”

Metabolic risk is often underestimated because it does not immediately disrupt work through hospitalization. Instead, it manifests as:

  • Fatigue
  • Slow recovery from illness
  • Higher complication rates
  • Earlier onset of chronic disease

By the time endocrine disorders surface as inpatient claims, the organization has lost most preventive leverage. From an insurance perspective, unmanaged metabolic risk increases claim severity in other systems, long-term medication dependence and renewal pressure driven by downstream claims.

How can HR reduce diabetes and thyroid risk in the workforce?

Section titled “How can HR reduce diabetes and thyroid risk in the workforce?”

Endocrine and metabolic disorders are the silent architects of workforce health risk. Their low inpatient visibility masks their central role in driving the most expensive and complex claims.

1. Treat abnormal screening results as intervention triggers

Section titled “1. Treat abnormal screening results as intervention triggers”

Screening identifies risk. Intervention prevents progression. Employees with abnormal HbA1c or thyroid markers should receive structured follow-up, including physician consultation, monitoring and lifestyle support. Without follow-up, screening provides no risk reduction.

2. Prioritize thyroid screening, especially for women

Section titled “2. Prioritize thyroid screening, especially for women”

Thyroid dysfunction is common, underdiagnosed and highly treatable. Routine thyroid screening enables early treatment, improves employee wellbeing and reduces pregnancy and metabolic complications.

3. Treat diabetes prevention as a long-term risk management programme

Section titled “3. Treat diabetes prevention as a long-term risk management programme”

The key intervention window exists before diabetes develops. Employees aged 31 to 40 with abnormal HbA1c represent the highest-impact intervention group. Preventing diabetes progression significantly reduces future cardiac, kidney and hospitalization costs.

4. Integrate metabolic risk management across cardiac, kidney and maternity programmes

Section titled “4. Integrate metabolic risk management across cardiac, kidney and maternity programmes”

Metabolic dysfunction is the shared upstream driver across multiple high-cost claim categories. Managing metabolic risk reduces downstream disease burden across multiple systems simultaneously.

  1. Pazcare claims and health check-up data, as described in Methods and data sources.